Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 298 entries
Sorted by: Best Match Show Resources per page
[Not Available].

Arab journal of urology

Lue TF, El-Sakka AI.
PMID: 26558081
Arab J Urol. 2013 Sep;11(3):193. doi: 10.1016/j.aju.2013.08.001. Epub 2013 Sep 02.

No abstract available.

Cite
Lue TF, El-Sakka AI. [Not Available]. Arab J Urol. 2013;11(3):193doi: 10.1016/j.aju.2013.08.001.
Lue, T. F., & El-Sakka, A. I. (2013). [Not Available]. Arab journal of urology, 11(3), 193. https://doi.org/10.1016/j.aju.2013.08.001
Lue, Tom F, and El-Sakka, Ahmed I. "[Not Available]." Arab journal of urology vol. 11,3 (2013): 193. doi: https://doi.org/10.1016/j.aju.2013.08.001
Lue TF, El-Sakka AI. [Not Available]. Arab J Urol. 2013 Sep;11(3):193. doi: 10.1016/j.aju.2013.08.001. Epub 2013 Sep 02. PMID: 26558081; PMCID: PMC4443012.
Copy Download .nbib Format: NLM
Broomcorn and foxtail millet were cultivated in Taiwan about 5000 years ago.

Botanical studies

Tsang CH, Li KT, Hsu TF, Tsai YC, Fang PH, Hsing YC.
PMID: 28510186
Bot Stud. 2017 Dec;58(1):3. doi: 10.1186/s40529-016-0158-2. Epub 2017 Jan 02.

BACKGROUND: Archaeobotanical remains of millet were found at the Nan-kuan-li East site in Tainan Science Park, southern Taiwan. This site, dated around 5000-4300 BP, is characterized by remains of the Tapenkeng culture, the earliest Neolithic culture found so far...

Cite
Tsang CH, Li KT, Hsu TF, et al. Broomcorn and foxtail millet were cultivated in Taiwan about 5000 years ago. Bot Stud. 2017;58(1):3doi: 10.1186/s40529-016-0158-2.
Tsang, C. H., Li, K. T., Hsu, T. F., Tsai, Y. C., Fang, P. H., & Hsing, Y. C. (2017). Broomcorn and foxtail millet were cultivated in Taiwan about 5000 years ago. Botanical studies, 58(1), 3. https://doi.org/10.1186/s40529-016-0158-2
Tsang, Chen-Hwa, et al. "Broomcorn and foxtail millet were cultivated in Taiwan about 5000 years ago." Botanical studies vol. 58,1 (2017): 3. doi: https://doi.org/10.1186/s40529-016-0158-2
Tsang CH, Li KT, Hsu TF, Tsai YC, Fang PH, Hsing YC. Broomcorn and foxtail millet were cultivated in Taiwan about 5000 years ago. Bot Stud. 2017 Dec;58(1):3. doi: 10.1186/s40529-016-0158-2. Epub 2017 Jan 02. PMID: 28510186; PMCID: PMC5430587.
Copy Download .nbib Format: NLM
Clinical Potentials of Cardiomyocytes Derived from Patient-Specific Induced Pluripotent Stem Cells.

Journal of clinical medicine

Ng KM, Law CY, Tse HF.
PMID: 26237594
J Clin Med. 2014 Oct 15;3(4):1105-23. doi: 10.3390/jcm3041105.

The lack of appropriate human cardiomyocyte-based experimental platform has largely hindered the study of cardiac diseases and the development of therapeutic strategies. To date, somatic cells isolated from human subjects can be reprogramed into induced pluripotent stem cells (iPSCs)...

Cite
Ng KM, Law CY, Tse HF. Clinical Potentials of Cardiomyocytes Derived from Patient-Specific Induced Pluripotent Stem Cells. J Clin Med. 2014;3(4):1105-23doi: 10.3390/jcm3041105.
Ng, K. M., Law, C. Y., & Tse, H. F. (2014). Clinical Potentials of Cardiomyocytes Derived from Patient-Specific Induced Pluripotent Stem Cells. Journal of clinical medicine, 3(4), 1105-23. https://doi.org/10.3390/jcm3041105
Ng, Kwong-Man, et al. "Clinical Potentials of Cardiomyocytes Derived from Patient-Specific Induced Pluripotent Stem Cells." Journal of clinical medicine vol. 3,4 (2014): 1105-23. doi: https://doi.org/10.3390/jcm3041105
Ng KM, Law CY, Tse HF. Clinical Potentials of Cardiomyocytes Derived from Patient-Specific Induced Pluripotent Stem Cells. J Clin Med. 2014 Oct 15;3(4):1105-23. doi: 10.3390/jcm3041105. PMID: 26237594; PMCID: PMC4470173.
Copy Download .nbib Format: NLM
A syndrome of erectile dysfunction in young men?.

Translational andrology and urology

Reed-Maldonado AB, Lue TF.
PMID: 27141452
Transl Androl Urol. 2016 Apr;5(2):228-34. doi: 10.21037/tau.2016.03.02.

No abstract available.

Cite
Reed-Maldonado AB, Lue TF. A syndrome of erectile dysfunction in young men?. Transl Androl Urol. 2016;5(2):228-34doi: 10.21037/tau.2016.03.02.
Reed-Maldonado, A. B., & Lue, T. F. (2016). A syndrome of erectile dysfunction in young men?. Translational andrology and urology, 5(2), 228-34. https://doi.org/10.21037/tau.2016.03.02
Reed-Maldonado, Amanda B, and Lue, Tom F. "A syndrome of erectile dysfunction in young men?." Translational andrology and urology vol. 5,2 (2016): 228-34. doi: https://doi.org/10.21037/tau.2016.03.02
Reed-Maldonado AB, Lue TF. A syndrome of erectile dysfunction in young men?. Transl Androl Urol. 2016 Apr;5(2):228-34. doi: 10.21037/tau.2016.03.02. PMID: 27141452; PMCID: PMC4837321.
Copy Download .nbib Format: NLM
A narrative review of cost-effectiveness analysis of people living with HIV treated with HAART: from interventions to outcomes.

ClinicoEconomics and outcomes research : CEOR

Tse WF, Yang W, Huang W.
PMID: 26316787
Clinicoecon Outcomes Res. 2015 Aug 11;7:431-9. doi: 10.2147/CEOR.S85535. eCollection 2015.

BACKGROUND: Since its introduction in 1996, highly active antiretroviral therapy (HAART), which involves the combination of antiretroviral drugs, has resulted in significant improvements in the morbidity, mortality, and life expectancy of HIV-infected patients. Numerous studies of the cost-effectiveness of...

Cite
Tse WF, Yang W, Huang W. A narrative review of cost-effectiveness analysis of people living with HIV treated with HAART: from interventions to outcomes. Clinicoecon Outcomes Res. 2015;7:431-9doi: 10.2147/CEOR.S85535.
Tse, W. F., Yang, W., & Huang, W. (2015). A narrative review of cost-effectiveness analysis of people living with HIV treated with HAART: from interventions to outcomes. ClinicoEconomics and outcomes research : CEOR, 7431-9. https://doi.org/10.2147/CEOR.S85535
Tse, Wah Fung, et al. "A narrative review of cost-effectiveness analysis of people living with HIV treated with HAART: from interventions to outcomes." ClinicoEconomics and outcomes research : CEOR vol. 7 (2015): 431-9. doi: https://doi.org/10.2147/CEOR.S85535
Tse WF, Yang W, Huang W. A narrative review of cost-effectiveness analysis of people living with HIV treated with HAART: from interventions to outcomes. Clinicoecon Outcomes Res. 2015 Aug 11;7:431-9. doi: 10.2147/CEOR.S85535. eCollection 2015. PMID: 26316787; PMCID: PMC4540173.
Copy Download .nbib Format: NLM
Commentary on high flow, non-ischemic, priapism.

Translational andrology and urology

Wu AK, Lue TF.
PMID: 26816695
Transl Androl Urol. 2012 Jun;1(2):109-12. doi: 10.3978/j.issn.2223-4683.2012.06.04.

No abstract available.

Cite
Wu AK, Lue TF. Commentary on high flow, non-ischemic, priapism. Transl Androl Urol. 2012;1(2):109-12doi: 10.3978/j.issn.2223-4683.2012.06.04.
Wu, A. K., & Lue, T. F. (2012). Commentary on high flow, non-ischemic, priapism. Translational andrology and urology, 1(2), 109-12. https://doi.org/10.3978/j.issn.2223-4683.2012.06.04
Wu, Alex K, and Lue, Tom F. "Commentary on high flow, non-ischemic, priapism." Translational andrology and urology vol. 1,2 (2012): 109-12. doi: https://doi.org/10.3978/j.issn.2223-4683.2012.06.04
Wu AK, Lue TF. Commentary on high flow, non-ischemic, priapism. Transl Androl Urol. 2012 Jun;1(2):109-12. doi: 10.3978/j.issn.2223-4683.2012.06.04. PMID: 26816695; PMCID: PMC4708203.
Copy Download .nbib Format: NLM
Xanthorrhizol: a review of its pharmacological activities and anticancer properties.

Cancer cell international

Oon SF, Nallappan M, Tee TT, Shohaimi S, Kassim NK, Sa'ariwijaya MS, Cheah YH.
PMID: 26500452
Cancer Cell Int. 2015 Oct 21;15:100. doi: 10.1186/s12935-015-0255-4. eCollection 2015.

Xanthorrhizol (XNT) is a bisabolane-type sesquiterpenoid compound extracted from Curcuma xanthorrhiza Roxb. It has been well established to possess a variety of biological activities such as anticancer, antimicrobial, anti-inflammatory, antioxidant, antihyperglycemic, antihypertensive, antiplatelet, nephroprotective, hepatoprotective, estrogenic and anti-estrogenic effects....

Cite
Oon SF, Nallappan M, Tee TT, et al. Xanthorrhizol: a review of its pharmacological activities and anticancer properties. Cancer Cell Int. 2015;15:100doi: 10.1186/s12935-015-0255-4.
Oon, S. F., Nallappan, M., Tee, T. T., Shohaimi, S., Kassim, N. K., Sa'ariwijaya, M. S., & Cheah, Y. H. (2015). Xanthorrhizol: a review of its pharmacological activities and anticancer properties. Cancer cell international, 15100. https://doi.org/10.1186/s12935-015-0255-4
Oon, Seok Fang, et al. "Xanthorrhizol: a review of its pharmacological activities and anticancer properties." Cancer cell international vol. 15 (2015): 100. doi: https://doi.org/10.1186/s12935-015-0255-4
Oon SF, Nallappan M, Tee TT, Shohaimi S, Kassim NK, Sa'ariwijaya MS, Cheah YH. Xanthorrhizol: a review of its pharmacological activities and anticancer properties. Cancer Cell Int. 2015 Oct 21;15:100. doi: 10.1186/s12935-015-0255-4. eCollection 2015. PMID: 26500452; PMCID: PMC4618344.
Copy Download .nbib Format: NLM
Peyronie's disease.

Current opinion in urology

El-Sakka AI, Lue TF.
PMID: 17035858
Curr Opin Urol. 1998 May;8(3):203-9. doi: 10.1097/00042307-199805000-00002.

The pathogenesis of Peyronie's disease is still not well understood. As a result, the treatment of Peyronie's disease remains a dilemma and new therapies continue to evolve. This article discusses present understanding, controversy and new discoveries related to this...

Cite
El-Sakka AI, Lue TF. Peyronie's disease. Curr Opin Urol. 1998;8(3):203-9doi: 10.1097/00042307-199805000-00002.
El-Sakka, A. I., & Lue, T. F. (1998). Peyronie's disease. Current opinion in urology, 8(3), 203-9. https://doi.org/10.1097/00042307-199805000-00002
El-Sakka, A I, and Lue, T F. "Peyronie's disease." Current opinion in urology vol. 8,3 (1998): 203-9. doi: https://doi.org/10.1097/00042307-199805000-00002
El-Sakka AI, Lue TF. Peyronie's disease. Curr Opin Urol. 1998 May;8(3):203-9. doi: 10.1097/00042307-199805000-00002. PMID: 17035858.
Copy Download .nbib Format: NLM
Combined xanthorrhizol-curcumin exhibits synergistic growth inhibitory activity via apoptosis induction in human breast cancer cells MDA-MB-231.

Cancer cell international

Cheah YH, Nordin FJ, Sarip R, Tee TT, Azimahtol HLP, Sirat HM, Rashid BAA, Abdullah NR, Ismail Z.
PMID: 19118501
Cancer Cell Int. 2009 Jan 02;9:1. doi: 10.1186/1475-2867-9-1.

BACKGROUND: It has been suggested that combined effect of natural products may improve the treatment effectiveness in combating proliferation of cancer cells. The present study was undertaken to evaluate the possibility that the combination of xanthorrhizol and curcumin might...

Cite
Cheah YH, Nordin FJ, Sarip R, et al. Combined xanthorrhizol-curcumin exhibits synergistic growth inhibitory activity via apoptosis induction in human breast cancer cells MDA-MB-231. Cancer Cell Int. 2009;9:1doi: 10.1186/1475-2867-9-1.
Cheah, Y. H., Nordin, F. J., Sarip, R., Tee, T. T., Azimahtol, H. L. P., Sirat, H. M., Rashid, B. A. A., Abdullah, N. R., & Ismail, Z. (2009). Combined xanthorrhizol-curcumin exhibits synergistic growth inhibitory activity via apoptosis induction in human breast cancer cells MDA-MB-231. Cancer cell international, 91. https://doi.org/10.1186/1475-2867-9-1
Cheah, Yew Hoong, et al. "Combined xanthorrhizol-curcumin exhibits synergistic growth inhibitory activity via apoptosis induction in human breast cancer cells MDA-MB-231." Cancer cell international vol. 9 (2009): 1. doi: https://doi.org/10.1186/1475-2867-9-1
Cheah YH, Nordin FJ, Sarip R, Tee TT, Azimahtol HLP, Sirat HM, Rashid BAA, Abdullah NR, Ismail Z. Combined xanthorrhizol-curcumin exhibits synergistic growth inhibitory activity via apoptosis induction in human breast cancer cells MDA-MB-231. Cancer Cell Int. 2009 Jan 02;9:1. doi: 10.1186/1475-2867-9-1. PMID: 19118501; PMCID: PMC2630298.
Copy Download .nbib Format: NLM
Words of wisdom. Re: feasibility of the use of phosphodiesterase type 5 inhibitors in a pharmacologic prevention program for recurrent priapism.

European urology

Lue TF, Bella AJ.
PMID: 17855853
Eur Urol. 2007 Sep;52(3):918-9. doi: 10.1016/j.eururo.2007.06.011.

No abstract available.

Cite
Lue TF, Bella AJ. Words of wisdom. Re: feasibility of the use of phosphodiesterase type 5 inhibitors in a pharmacologic prevention program for recurrent priapism. Eur Urol. 2007;52(3):918-9doi: 10.1016/j.eururo.2007.06.011.
Lue, T. F., & Bella, A. J. (2007). Words of wisdom. Re: feasibility of the use of phosphodiesterase type 5 inhibitors in a pharmacologic prevention program for recurrent priapism. European urology, 52(3), 918-9. https://doi.org/10.1016/j.eururo.2007.06.011
Lue, Tom F, and Bella, Anthony J. "Words of wisdom. Re: feasibility of the use of phosphodiesterase type 5 inhibitors in a pharmacologic prevention program for recurrent priapism." European urology vol. 52,3 (2007): 918-9. doi: https://doi.org/10.1016/j.eururo.2007.06.011
Lue TF, Bella AJ. Words of wisdom. Re: feasibility of the use of phosphodiesterase type 5 inhibitors in a pharmacologic prevention program for recurrent priapism. Eur Urol. 2007 Sep;52(3):918-9. doi: 10.1016/j.eururo.2007.06.011. PMID: 17855853.
Copy Download .nbib Format: NLM
Words of wisdom. Re: Effect of nightly versus on-demand vardenafil on recovery of erectile function in men following bilateral nerve-sparing radical prostatectomy.

European urology

Shindel AW, Lue TF.
PMID: 20965040
Eur Urol. 2009 Dec;56(6):1088-9. doi: 10.1016/j.eururo.2009.09.010.

No abstract available.

Cite
Shindel AW, Lue TF. Words of wisdom. Re: Effect of nightly versus on-demand vardenafil on recovery of erectile function in men following bilateral nerve-sparing radical prostatectomy. Eur Urol. 2009;56(6):1088-9doi: 10.1016/j.eururo.2009.09.010.
Shindel, A. W., & Lue, T. F. (2009). Words of wisdom. Re: Effect of nightly versus on-demand vardenafil on recovery of erectile function in men following bilateral nerve-sparing radical prostatectomy. European urology, 56(6), 1088-9. https://doi.org/10.1016/j.eururo.2009.09.010
Shindel, Alan W, and Lue, Tom F. "Words of wisdom. Re: Effect of nightly versus on-demand vardenafil on recovery of erectile function in men following bilateral nerve-sparing radical prostatectomy." European urology vol. 56,6 (2009): 1088-9. doi: https://doi.org/10.1016/j.eururo.2009.09.010
Shindel AW, Lue TF. Words of wisdom. Re: Effect of nightly versus on-demand vardenafil on recovery of erectile function in men following bilateral nerve-sparing radical prostatectomy. Eur Urol. 2009 Dec;56(6):1088-9. doi: 10.1016/j.eururo.2009.09.010. PMID: 20965040; PMCID: PMC3839657.
Copy Download .nbib Format: NLM
Plasmodium berghei ANKA Infection in ICR Mice as a Model of Cerebral Malaria.

Iranian journal of parasitology

Basir R, Rahiman SF, Hasballah K, Chong W, Talib H, Yam M, Jabbarzare M, Tie T, Othman F, Moklas M, Abdullah W, Ahmad Z.
PMID: 23323093
Iran J Parasitol. 2012;7(4):62-74.

BACKGROUND: Animal models with various combination of host-parasite have long been employed to study malaria pathogenesis. Here, we describe the combination of Plasmodium berghei ANKA infection in inbred ICR mice as a model of cerebral malaria (CM).METHODS: Infection in...

Cite
Basir R, Rahiman SF, Hasballah K, et al. Plasmodium berghei ANKA Infection in ICR Mice as a Model of Cerebral Malaria. Iran J Parasitol. 2012;7(4):62-74
Basir, R., Rahiman, S. F., Hasballah, K., Chong, W., Talib, H., Yam, M., Jabbarzare, M., Tie, T., Othman, F., Moklas, M., Abdullah, W., & Ahmad, Z. (2012). Plasmodium berghei ANKA Infection in ICR Mice as a Model of Cerebral Malaria. Iranian journal of parasitology, 7(4), 62-74.
Basir, R, et al. "Plasmodium berghei ANKA Infection in ICR Mice as a Model of Cerebral Malaria." Iranian journal of parasitology vol. 7,4 (2012): 62-74.
Basir R, Rahiman SF, Hasballah K, Chong W, Talib H, Yam M, Jabbarzare M, Tie T, Othman F, Moklas M, Abdullah W, Ahmad Z. Plasmodium berghei ANKA Infection in ICR Mice as a Model of Cerebral Malaria. Iran J Parasitol. 2012;7(4):62-74. PMID: 23323093; PMCID: PMC3537477.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 298 entries